arrow
A

Alain Gelibter

Sapienza Universita di Roma
H指数:36
被引数:4,690

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-line treatment in EGFR-mutated non-small cell lung cancer: brief report of an individual patient data comparison of phase 3 clinical trials

EGFR突变非小细胞肺癌的一线治疗:一项基于个体患者数据的Ⅲ期临床 trial 比较的简报

2025-11-190
OAAI
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients

Anti-PD1疗法在转移性非癌基因依赖的NSCLC患者中诱导Ki67 CD8 T细胞的早期扩增

2024-12-180
OAAI
Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long-term single centre follow-up study

睾丸超声特征预测双侧睾丸生殖细胞肿瘤的未来风险: 一项长期单中心随访研究

2024-07-300
OA
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)

奥希替尼在具有罕见表皮生长因子受体突变的非小细胞肺癌中的活性: 回顾性观察性多中心研究 (ARTICUNO)

2024-06-011
OAAI
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
2024-05-013
PRE
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort

抗核抗体可预测免疫检查点抑制剂治疗的无症状患者免疫相关不良事件的发展: 来自单中心队列的结果

2024-04-100
OAAI
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line

CD137和调节性T细胞作为接受免疫治疗的晚期非癌基因依赖性NSCLC患者的独立预后因素

2024-04-034
OAAI
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials
2023-12-0121
OAAI
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario

化疗或免疫检查点抑制剂治疗的转移性非小细胞肺癌患者的肾功能结局: 意外情况

2022-04-246
OAAI
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status
2022-01-215
OAAI
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments

两种基于血液的基因分型检测在一线治疗失败的非小细胞肺癌患者中KRAS G12C突变的比较

2021-11-254
OAAI
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

生命晚期的PD-1/PD-L1检查点抑制剂: 来自大型多中心队列的临时分析

2021-06-2415
OAAI